Antipsychotic-induced weight gain is a major management problem for clinicians. It has
been shown that weight gain and obesity lead to increased cardiovascular and …

Importance Antipsychotics are used increasingly in youth for nonpsychotic and off-label
indications, but cardiometabolic adverse effects and (especially) type 2 diabetes mellitus …

Context Although antipsychotic treatment has recently increased, little is known about how
this development has differentially affected the office-based care of adults and young people …

Importance Despite concerns about rising treatment of young people with antipsychotic
medications, little is known about trends and patterns of their use in the United States …

Introduction: New antipsychotics continuously arrive on the market, which thereby influences
the approved and off-label prescribing (OLP) schemes. We aimed to identify the recent …

The Food and Drug Administration has approved the use of antipsychotic medications in
some children and adolescents with severe emotional and behavioral disorders. However …

Most major psychiatric disorders have an onset in childhood or adolescence in a sizeable
proportion of patients, and earlier onset disorders often have a severe and chronic course …

The objectives of the study were as follows: to examine the national trend of pediatric
atypical antipsychotic (AAP) use in the United States; to identify primary mental disorders …

Objective Although irritability and aggression are relevant treatment targets in autism
spectrum disorders (ASDs) and intellectual disability (ID) that may prompt antipsychotic use …

BACKGROUND: Although the increase in treatment of children and adolescents with
antipsychotic medications has been well documented, much less is known about the factors …